Works matching IS 10584838 AND DT 2019 AND VI 69
Results: 516
Ending the Human Immunodeficiency Virus Pandemic: Optimizing the Prevention and Treatment Toolkits.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2212, doi. 10.1093/cid/ciz998
- By:
- Publication type:
- Article
In the Literature.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. iii, doi. 10.1093/cid/ciz922
- Publication type:
- Article
News.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. i, doi. 10.1093/cid/ciz884
- Publication type:
- Article
The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward Elimination.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2218, doi. 10.1093/cid/ciz714
- By:
- Publication type:
- Article
Erratum.
- Published in:
- 2019
- Publication type:
- Correction Notice
Reply to Jain et al.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Genetic Evidence That Naive T Cells Can Contribute Significantly to the Human Immunodeficiency Virus Intact Reservoir: Time to Re-evaluate Their Role.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Is Oral Ribavirin for the Treatment of Respiratory Syncytial Virus in High-risk Hematopoietic Stem Cell Transplant Recipients Really Safe?
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Reply to Khoruts and Sadowsky.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Letter to the Editor.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Reply to Skowronski and De Serres.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Evidence in a Cluster Randomized Controlled Trial of Increased 2009 Pandemic Risk Associated With 2008–2009 Seasonal Influenza Vaccine Receipt.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Reply to Taramasso et al.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Immunonutrition in Human Immunodeficiency Virus Infection: Which Populations to Target?
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Decreased Tenofovir Diphosphate Concentrations in a Transgender Female Cohort: Implications for Human Immunodeficiency Virus Preexposure Prophylaxis.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2201, doi. 10.1093/cid/ciz290
- By:
- Publication type:
- Article
The Impact of Human Immunodeficiency Virus Exposure on Respiratory Syncytial Virus–associated Severe Respiratory Illness in South African Infants, 2011–2016.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2208, doi. 10.1093/cid/ciz288
- By:
- Publication type:
- Article
Preemptive Tecovirimat Use in an Active Duty Service Member Who Presented With Acute Myeloid Leukemia After Smallpox Vaccination.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2205, doi. 10.1093/cid/ciz286
- By:
- Publication type:
- Article
Preventing Tuberculosis Disease: Making a Case for Enhanced Tuberculosis Screening in People Immigrating to Low-incidence Countries.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2109, doi. 10.1093/cid/ciz192
- By:
- Publication type:
- Article
Estimated Impact of World Health Organization Latent Tuberculosis Screening Guidelines in a Region With a Low Tuberculosis Incidence: Retrospective Cohort Study.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2101, doi. 10.1093/cid/ciz188
- By:
- Publication type:
- Article
By ZEUS! Can We Use Intravenous Fosfomycin for Complicated Urinary Tract Infections?
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2057, doi. 10.1093/cid/ciz185
- By:
- Publication type:
- Article
Fosfomycin for Injection (ZTI-01) Versus Piperacillin-tazobactam for the Treatment of Complicated Urinary Tract Infection Including Acute Pyelonephritis: ZEUS, A Phase 2/3 Randomized Trial.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2045, doi. 10.1093/cid/ciz181
- By:
- Publication type:
- Article
Patterns of Hepatitis C Virus Transmission in Human Immunodeficiency Virus (HIV)–infected and HIV-negative Men Who Have Sex With Men.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2127, doi. 10.1093/cid/ciz160
- By:
- Publication type:
- Article
Trichomonas vaginalis Virus Among Women With Trichomoniasis and Associations With Demographics, Clinical Outcomes, and Metronidazole Resistance.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2170, doi. 10.1093/cid/ciz146
- By:
- Publication type:
- Article
High-risk Human Papilloma Virus Testing Improves Diagnostic Performance to Predict Moderate- to High-grade Anal Intraepithelial Neoplasia in Human Immunodeficiency Virus–infected Men Who Have Sex With Men in Low-to-Absent Cytological Abnormalities.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2185, doi. 10.1093/cid/ciz144
- By:
- Publication type:
- Article
Seroprotection at Different Levels of the Healthcare System After Routine Vaccination With Diphtheria-Tetanus-Pertussis whole cell–Hepatitis B–Haemophilus influenzae Type B in Lao People's Democratic Republic.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2136, doi. 10.1093/cid/ciz143
- By:
- Publication type:
- Article
Changes in Otitis Media Episodes and Pressure Equalization Tube Insertions Among Young Children Following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine: A Birth Cohort–based Study.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2162, doi. 10.1093/cid/ciz142
- By:
- Publication type:
- Article
A Dose-finding Study of a Wild-type Influenza A(H3N2) Virus in a Healthy Volunteer Human Challenge Model.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2082, doi. 10.1093/cid/ciz141
- By:
- Publication type:
- Article
The Impact of Improved Water, Sanitation, and Hygiene on Oral Rotavirus Vaccine Immunogenicity in Zimbabwean Infants: Substudy of a Cluster-randomized Trial.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2074, doi. 10.1093/cid/ciz140
- By:
- Publication type:
- Article
Indirect Effects of 10-Valent Pneumococcal Conjugate Vaccine Against Adult Pneumococcal Pneumonia in Rural Western Kenya.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2177, doi. 10.1093/cid/ciz139
- By:
- Publication type:
- Article
Rotavirus Vaccines Set to Make Inroads in Asia.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2071, doi. 10.1093/cid/ciz137
- By:
- Publication type:
- Article
Impact of Rotavirus Vaccine Introduction in Children Less Than 2 Years of Age Presenting for Medical Care With Diarrhea in Rural Matlab, Bangladesh.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2059, doi. 10.1093/cid/ciz133
- By:
- Publication type:
- Article
Prospective Clinical and Molecular Evaluation of Potential Plasmodium ovale curtisi and wallikeri Relapses in a High-transmission Setting.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2119, doi. 10.1093/cid/ciz131
- By:
- Publication type:
- Article
Persistent Low-level Viremia While on Antiretroviral Therapy Is an Independent Risk Factor for Virologic Failure.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2145, doi. 10.1093/cid/ciz129
- By:
- Publication type:
- Article
Differences by Sex in Cardiovascular Comorbid Conditions Among Older Adults (Aged 50–64 or ≥65 Years) Receiving Care for Human Immunodeficiency Virus.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2091, doi. 10.1093/cid/ciz126
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness Against Hospitalization in Fully and Partially Vaccinated Children in Israel: 2015–2016, 2016–2017, and 2017–2018.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2153, doi. 10.1093/cid/ciz125
- By:
- Publication type:
- Article
Methicillin-susceptible and Methicillin-resistant Staphylococcus aureus Bacteremia: Nationwide Estimates of 30-Day Readmission, In-hospital Mortality, Length of Stay, and Cost in the United States.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2112, doi. 10.1093/cid/ciz123
- By:
- Publication type:
- Article
Erratum.
- Published in:
- 2019
- Publication type:
- Correction Notice
Erratum.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Charting the Path Forward: Development, Goals and Initiatives of the 2019 Infectious Diseases of America Strategic Plan.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. e1, doi. 10.1093/cid/ciz1040
- By:
- Publication type:
- Article
2019 CID Reviewer Recognition List.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. e8, doi. 10.1093/cid/ciz1022
- Publication type:
- Article
Erratum.
- Published in:
- 2019
- Publication type:
- Correction Notice
Ending the Human Immunodeficiency Virus Epidemic: Towards an Evidence-Based Approach.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2199, doi. 10.1093/cid/ciz1018
- By:
- Publication type:
- Article
Ending the Epidemic in America Will Not Happen if the Status Quo Continues: Modeled Projections for Human Immunodeficiency Virus Incidence in 6 US Cities.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2195, doi. 10.1093/cid/ciz1015
- By:
- Publication type:
- Article
48-Year-Old Male With Febrile Neutropenia and Massive Hemolysis.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, p. S565, doi. 10.1093/cid/ciz830
- By:
- Publication type:
- Article
Pathogen-focused Clinical Development to Address Unmet Medical Need: Cefiderocol Targeting Carbapenem Resistance.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, p. S559, doi. 10.1093/cid/ciz829
- By:
- Publication type:
- Article
Pharmacokinetic and Pharmacodynamic Profiles of Cefiderocol, a Novel Siderophore Cephalosporin.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, p. S552, doi. 10.1093/cid/ciz828
- By:
- Publication type:
- Article
In Vitro Activity of Cefiderocol Against a Broad Range of Clinically Important Gram-negative Bacteria.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, p. S544, doi. 10.1093/cid/ciz827
- By:
- Publication type:
- Article
Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, p. S538, doi. 10.1093/cid/ciz826
- By:
- Publication type:
- Article
The Role of Iron and Siderophores in Infection, and the Development of Siderophore Antibiotics.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, p. S529, doi. 10.1093/cid/ciz825
- By:
- Publication type:
- Article